EmVenio Blog
Our research team continues momentum of growth with two new principal investigators
We're thrilled to announce the addition of Michelle Mallitz, M.D., and Thomas Wade, M.D., to our team to serve as principal investigators. In their roles, they will oversee and conduct objective clinical research to ensure independent, high quality and reproducible...
EmVenio Research September 2023 Community Engagement Overview
We are excited to bring you the latest updates from our recent activities and initiatives. EmVenio Research continues to make strides in promoting our studies and health screenings, as well as engaging with local communities and organizations. We are excited to...
EmVenio and Inclusive join forces to streamline community engagement and research site solutions
We're excited to announce our collaboration with Research Grid's Inclusive to support community engagement across the United States and the United Kingdom. EmVenio is using Inclusive, a pioneering community engagement software and vital technology that supports rapid...
EmVenio Research Partners with RealTime Software Solutions for Advanced Mobile-Optimized Technology Solutions
We're excited to announce a strategic partnership with RealTime Software Solutions, LLC, a renowned provider of cutting-edge, digitally-optimized technologies designed for clinical research sites, CROs (clinical research organizations) and sponsors. "RealTime Software...
EmVenio Research expands clinical research team to streamline efficiency and compliance processes
Christine Scheuring and Vickie Leathers joined EmVenio Research to manage clinical research teams and processes.
The Ongoing Need for Annual Clinical Trials in Infectious Diseases
Infectious diseases such as the flu, COVID-19 and RSV (Respiratory Syncytial Virus) pose a significant global health challenge, leading to substantial morbidity and mortality each year. To combat these diseases effectively, it is crucial to conduct annual clinical...
A reason to celebrate!
This month marks our first year as EmVenio Research! EmVenio Research was founded in August 2022 with the mission to deliver clinical trial access to underrepresented and underserved communities and ensure research participants begin to accurately reflect our...
EmVenio Research July 2023 Community Engagement Overview
During the month of July, we continued our commitment to being present in the communities we service and collaborate with through a series of events and partnerships across various states. We aim to raise awareness about our groundbreaking research work and foster...
EmVenio Research adds principal investigators to research team
Please join us in welcoming Dr. Stephen Blank, M.D., and Dr. Suzanne Swan, M.D., who've joined our team as principal investigators. In their roles, they will oversee and conduct objective clinical research to ensure independent, high quality and reproducible results,...
EmVenio Research and TrialHub partner to optimize patient participation and accelerate site selection for clinical trials
EmVenio Research has partnered with TrialHub to conduct a wider range of clinical trials for new life-saving treatments.
5 ways to make your next clinical trial more inclusive
Diseases can affect individuals in different ways. In order to ensure the success and effectiveness of clinical trials, it is crucial to have a diverse range of individuals from different communities participate. By including people from various backgrounds,...
EmVenio Research expands internationally with 10 research sites in the U.K.
U.S.-based researcher and EMS Healthcare collaborate to conduct commercial clinical trials through a network of mobile research sites. DURHAM, N.C., June 20, 2023 – Community research provider EmVenio Research today announced its international expansion with the...